Back to News
Market Impact: 0.1
Teva Pharmaceutical Industries Limited Elects Dr. David J. Brailer to Board of Directors Effective November 3, 2026
Source: Nasdaq
Management & GovernanceHealthcare & Biotech
Teva’s Board elected Dr. David J. Brailer as a director effective November 3, 2026. His term runs until Teva’s 2027 annual meeting of shareholders; the article text provided is truncated before further details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
TEVA0.00
More News
- Meta says automation wrongly took down No Kings and a Senate candidate’s page. It’s automating more anyway
- Apple's Happy Holiday Forecast Overshadowed by Shrinking Margin
- Disney plans several thousand layoffs, asks some managers to cut costs by up to 20%
- Aussie Adobe assailant Canva announces layoffs in re-org affecting 22% of staff
- OpenAI’s hiring of former Army Secretary just 2 months after Pentagon resignation is part of a ‘trend’ of it pivoting resources to defense projects
- Midterm elections could jolt stocks if Democrats sweep Congress